For approximately 30 years, hematologists have sought the humoralregulator of platelet production, thrombopoietin.1 Althougha factor with the appropriate physiologic effects was partiallypurified, the goal continued to evade researchers until 1994,when three laboratories simultaneously reported that c-Mpl ligandhad the characteristics of thrombopoietin.2 Synonyms for thrombopoietinin the literature are c-Mpl ligand, mpl ligand, megapoietin,and megakaryocyte growth and development factor (a truncatedversion of thrombopoietin).
What explains the fact that thrombopoietin was ultimately purifiedand characterized by five laboratories almost simultaneously?In 1992, Wendling and colleagues described the c-mpl gene, thecellular homologue of v-. . . [Full Text of this Article]
References
This article has been cited by other articles:
Goulis, J, Chau, T N, Jordan, S, Mehta, A B, Watkinson, A, Rolles, K, Burroughs, A K
(1999). Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut
44: 754-758
[Abstract][Full Text]
Kaplan, A., Kaplan, S., Marcoe, K. F., Sauvage, L. R., Hammond, W. P.
(1998). The Effect of Hematopoietic Growth Factors on Platelet Aggregability. CLIN APPL THROMB HEMOST
4: 238-242
[Abstract]
Baker, G. R., Levin, J.
(1998). Transient Thrombocytopenia Produced by Administration of Macrophage Colony-Stimulating Factor: Investigations of the Mechanism. Blood
91: 89-99
[Abstract][Full Text]